Orchestra BioMed Holdings, Inc. (OBIO) Quick Ratio
- Quick ratio · latest quarter: Value 8.17×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 8.17× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $110.01M ÷ $13.47M ≈ 8.17× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 110.01M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 13.47M USD | Liabilities, Current |
| Cash and equivalents | 20.47M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 89.49M USD | Marketable Securities, Current |
| Customer receivables | 51.00K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 250.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $110.01M | $13.47M | $20.47M | $89.49M | $51.00K | $250.00K | 8.17× |
| 2026-03-31 | $94.48M | $13.69M | $28.37M | $66.03M | $84.00K | $277.00K | 6.90× |
| 2025-12-31 | $106.61M | $16.74M | $34.69M | $71.82M | $95.00K | $310.00K | 6.37× |
| 2025-09-30 | $95.87M | $20.66M | $42.01M | $53.81M | $52.00K | $365.00K | 4.64× |
| 2025-06-30 | $34.01M | $17.06M | $18.75M | $15.18M | $83.00K | $185.00K | 1.99× |
| 2025-03-31 | $49.97M | $15.49M | $18.35M | $31.54M | $89.00K | $135.00K | 3.23× |
| 2024-12-31 | $66.90M | $16.21M | $22.26M | $44.55M | $92.00K | $173.00K | 4.13× |
| 2024-09-30 | $67.04M | $16.22M | $25.61M | $41.32M | $115.00K | $234.00K | 4.13× |
| 2024-06-30 | $65.26M | $14.50M | $23.71M | $41.47M | $80.00K | $70.00K | 4.50× |
| 2024-03-31 | $75.08M | $10.42M | $23.32M | $51.69M | $67.00K | $115.00K | 7.21× |
| 2023-12-31 | $87.63M | $11.21M | $30.56M | $56.97M | $99.00K | $146.00K | 7.82× |
| 2023-09-30 | $108.57M | $21.47M | $19.08M | $89.41M | $86.00K | $137.00K | 5.06× |
| 2023-06-30 | $117.88M | $11.86M | $16.41M | $101.30M | $171.00K | $178.00K | 9.94× |
| 2023-03-31 | $127.21M | $12.06M | $18.70M | $108.44M | $76.00K | $232.00K | 10.55× |
| 2022-12-31 | (m) | $1.74M | $175.16K | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $1.44M | $735.22K | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $1.10M | $1.31M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $306.54K | $1.42M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $165.54K | $1.75M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $136.83K | $1.78M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $194.89K | $1.91M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $174.47K | $1.95M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $118.96K | $2.03M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $71.44K | $2.04M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $193.69K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |